Skip to main content
. Author manuscript; available in PMC: 2016 Dec 15.
Published in final edited form as: Eur J Pharmacol. 2015 Nov 6;769:134–142. doi: 10.1016/j.ejphar.2015.11.008

Fig. 6.

Fig. 6

A schematic representation of the working hypothesis that dasatinib and PP2 inhibit TGFβ-induced αSMA expression and fibronectin assembly, in part via regulation of Src and SRF, thereby attenuating myofibroblast differentiation.